Su1384 EUS-GUIDED RADIOFREQUENCY ABLATION (EUS-RFA) FOR PANCREATIC NEUROENDOCRINE TUMORS AND CYSTIC MUCINOUS NEOPLASMS: A PILOT STUDY OF SAFETY, FEASIBILITY AND EFFICACY

Volume: 87, Issue: 6, Pages: AB332 - AB333
Published: Jun 1, 2018
Abstract
Preliminary case-reports deem EUS-RFA as a potential effective therapy for selected patients with pancreatic malignancies unfit for or refusing surgery. Recent development of EUS-RFA catheters opens up a potential, minimally invasive treatment option. However, there are scarce data about their real safety, efficcacy and type of lesions potentially treatables. We aimed to assess the feasibility, efficacy, adverse events and early results of...
Paper Details
Title
Su1384 EUS-GUIDED RADIOFREQUENCY ABLATION (EUS-RFA) FOR PANCREATIC NEUROENDOCRINE TUMORS AND CYSTIC MUCINOUS NEOPLASMS: A PILOT STUDY OF SAFETY, FEASIBILITY AND EFFICACY
Published Date
Jun 1, 2018
Volume
87
Issue
6
Pages
AB332 - AB333
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.